Canopy Growth Corp's stock is experiencing a notable decline in today's trading session, raising concerns among investors.
Canopy Growth Corp (WEED.TO) is facing a challenging day in the market, with its stock price sliding by 3.65% to CA$1.32. This downturn comes despite recent positive developments in the cannabis sector, including a reported revenue growth of 13% in the first quarter of fiscal 2027.
Investor takeaway: Investors should be cautious, as today's decline may signal underlying issues despite the company's recent revenue growth.
Advertisement
Canopy Growth Corp
WEED.TO
WEED.TO
Canopy Growth Corp
WealthAwesomeAdvertisement
Market cap
$614.33M
52W high
$3.28
52W low
$1.18
1W change
+6.20%
Beta
2.41
Analyst Price Targets
Based on analyst covering WEED
Wall Street analysts forecast WEED stock price to rise 47.4% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$2.02
+47.4% Upside
Current Price
C$1.37
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Advertisement
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on WEED's historical volatility
30-Day Vol
40.6%
Annualized
90-Day Vol
62.1%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$1.15
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$1.29 | C$1.12 – C$1.48 |
| 60 trading days | C$1.22 | C$1.00 – C$1.48 |
| 90 trading days | C$1.15 | C$0.90 – C$1.46 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Canopy Growth Corp's stock down 3.65% today
Advertisement
The stock price drop reflects investor concerns despite a positive earnings report showing revenue growth and reduced losses.
Bull case
Canopy Growth recently reported a significant reduction in losses and a 13% increase in revenue. This suggests that the company has potential for recovery if it can keep up this positive trend.
Bear case
The stock's decline today raises questions about market confidence, especially given ongoing challenges like the reduction in Canada's Veterans Affairs medical cannabis reimbursement rate.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
